Codexis
  • Focus Areas
    • Therapeutics
    • Life Sciences
    • Sustainable Manufacturing
      • Pharma Manufacturing
      • Food & Nutrition
      • Industrial Applications
  • Technology
  • Products
    • Discovery and Development
    • Scale-up and Supply
    • Biocatalytic Enzymes
  • Partnership
    • Partners
    • Opportunities
  • Investors
  • Company
    • About Us
    • Team
      • Management
      • Board of Directors
    • Careers
    • News
    • Events
    • Resources
    • COVID-19 Response
    • Contact
  • Search
Open Mobile Menu

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 05, 2019 7:00am EST

Codexis to Participate in Two Investment Conferences in March

Feb 26, 2019 4:05pm EST

Codexis Reports 2018 Fourth Quarter and Full Year Financial Results

Feb 25, 2019 7:00am EST

Codexis Names Laurie Heilmann Senior Vice President of Business Development and Marketing

Feb 19, 2019 7:00am EST

Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26

Feb 14, 2019 7:00am EST

Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria

Feb 06, 2019 7:00am EST

Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan

Feb 04, 2019 4:05pm EST

Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck

Nov 08, 2018 4:05pm EST

Codexis Reports Third Quarter 2018 Financial Results

Nov 08, 2018 7:00am EST

Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114

Nov 07, 2018 4:05pm EST

Codexis to Present at Two Investment Conferences in November

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …12
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
twitterlinkedin
ContactInvestorsCareers

© 2021 Codexis. All rights reserved. Legal

Back To Top
Close search
Search